RU 486 Abortion Pill
The subcommittee heard from the French inventor of RU486, contraception researchers, and critics of the drug on the safety and… read more
The subcommittee heard from the French inventor of RU486, contraception researchers, and critics of the drug on the safety and effectiveness of RU486, the so-called abortion pill. RU486 is a drug that can be taken to cause an abortion during the first nine weeks of a pregnancy. It is also being tested as a possible treatment for breast cancer. Great Britain and France have approved the drug for general use. RU486 is not available in the United States, the drug’s manufacturer says, because of fears that anti-abortion groups would encourage a boycott against its products. Dr. Baulieu is the developer of RU486. close
*The transcript for this program was compiled from uncorrected Closed Captioning.
People in this video
- David Baird Professor Edinburgh University->OB-GYN
- Etienne Baulieu Researcher Department de Chimie Biologique
- Annie Bureau-Roger Physician Hospital Broussals, Paris, France->OB-GYN
- Marc Byademan Researcher Edinburgh University->OB-GYN
- Dilys Cossey Chairman British Family Planning Association
- Jacqueline Forrest Vice President Alan Guttmacher Institute->Research
- Richard Glasgow Director National Right to Life Committee->Education
- David Grimes Professor University of Southern California->OB-GYN
- Gary Hodgen Researcher East Virginia Medical School->OB-GYN
- Roderick MacKenzie President Gynopharma, Inc.
- Eleanor Smeal President Feminist Majority Foundation
- Beverly Winikoff Senior Medical Adviser Population Council
- Ron Wyden U.S. Representative [D] Oregon
Surgeon General's Report on Abortion
The Subcommittee held a hearing on the Medical and Psychological Impact of Abortion.
A rally was held in Washington, DC in support of abortion rights for women.
Mobilize for Women's Lives Rally, Part 1
The rally occurred at the Lincoln Memorial.
Mobilize for Women's Lives Rally, Part 2